Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Current Opinion in Hematology|February 9, 2024
Signaling networks guiding erythropoiesisShilpa Kuttikrishnan, Kirti S Prabhu, Abdul Q Khan, et al.Seminars in Cancer Biology|August 5, 2022
Dysregulated FOXM1 signaling in the regulation of cancer stem cellsGulab Sher, Tariq Masoodi, Kalyani Patil, et al.Leukemia & Lymphoma|August 9, 2021
Thiostrepton inhibits growth and induces apoptosis by targeting FoxM1/SKP2/MTH1 axis in B-precursor acute lymphoblastic leukemia cellsShilpa Kuttikrishnan, Kirti S Prabhu, Abdul Q Khan, et al.Pathology, Research and Practice|February 2, 2024
Beyond genetics: Exploring the role of epigenetic alterations in breast cancerKirti S Prabhu, Hana Q Sadida, Shilpa Kuttikrishnan, et al.Pathology, Research and Practice|July 17, 2024
Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic targetNuha Ahmad, Safwan Moton, Shilpa Kuttikrishnan, et al.Nutrition & Metabolism|March 7, 2017
Potential therapeutic targets of Guggulsterone in cancerAjaz A Bhat, Kirti S Prabhu, Shilpa Kuttikrishnan, et al.Frontiers in Pharmacology|March 4, 2024
Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancerAbbas Khan, Yasir Waheed, Shilpa Kuttikrishnan, et al.Seminars in Cell & Developmental Biology|October 10, 2022
The cross-talk between miRNAs and JAK/STAT pathway in cutaneous T cell lymphoma: Emphasis on therapeutic opportunitiesKalyani Patil, Gulab Sher, Shilpa Kuttikrishnan, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 30, 2024
H2AX: A key player in DNA damage response and a promising target for cancer therapyKirti S Prabhu, Shilpa Kuttikrishnan, Nuha Ahmad, et al.Future Medicinal Chemistry|April 6, 2018
Embelin: a benzoquinone possesses therapeutic potential for the treatment of human cancerKirti S Prabhu, Iman W Achkar, Shilpa Kuttikrishnan, et al.Pageof 5